Quick Answer
HEALTHEQUITY, INC. reported Total Revenue of $1.31 billion for fiscal year 2026.
HEALTHEQUITY, INC. — Key Financials by Year
| Metric | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Total Revenue | $1.31B +9.5% |
$1.20B +20.0% |
$999.59M +16.0% |
$861.75M +13.9% |
$756.56M +3.1% |
$733.57M +37.9% |
| Revenue (ASC 606) | $1.31B +9.5% |
$1.20B +20.0% |
$999.59M +16.0% |
$861.75M +13.9% |
$756.56M +3.1% |
$733.57M +37.9% |
| Net Income | $215.20M +122.5% |
$96.70M +73.6% |
$55.71M +313.1% |
-$26.14M +41.0% |
-$44.29M -601.3% |
$8.83M -77.7% |
| Diluted EPS | $2.46 +125.7% |
$1.09 +70.3% |
$0.64 +306.5% |
-$0.31 +41.5% |
-$0.53 -541.7% |
$0.12 -79.3% |
| Total Assets | $3.38B -2.0% |
$3.45B +9.0% |
$3.16B +2.4% |
$3.09B -0.6% |
$3.11B +14.6% |
$2.71B +5.7% |
| Cash and Equivalents | $318.93M +7.8% |
$295.95M -26.7% |
$403.98M +58.9% |
$254.27M +12.8% |
$225.41M -31.4% |
$328.80M +71.5% |
| Long-Term Debt | $957.38M -9.4% |
$1.06B +20.7% |
$874.97M -3.6% |
$907.84M -1.5% |
$922.08M -0.2% |
$924.22M -21.8% |
| Stockholders Equity | $2.11B -0.4% |
$2.11B +3.9% |
$2.04B +7.4% |
$1.90B +2.3% |
$1.85B +34.4% |
$1.38B +33.8% |
| R&D Expense | $262.51M +9.6% |
$239.51M +9.5% |
$218.81M +13.2% |
$193.38M +22.9% |
$157.36M +26.1% |
$124.81M +60.9% |
| Operating Income | $322.46M +98.6% |
$162.33M +37.9% |
$117.70M +1199.5% |
$9.06M +137.4% |
-$24.24M -171.3% |
$34.01M -55.8% |
| Gross Profit | $913.12M +17.5% |
$777.26M +24.8% |
$622.64M +26.6% |
$491.94M +15.8% |
$424.76M +2.3% |
$415.33M +27.4% |
| Shares Outstanding | 85.01M -1.8% |
86.54M +0.5% |
86.13M +1.6% |
84.76M +1.2% |
83.78M +8.6% |
77.17M +8.6% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | October 31, 2025 | $322.16M | +7.2% | -1.1% |
| Revenue (ASC 606) | October 31, 2025 | $322.16M | +7.2% | -1.1% |
| Net Income | October 31, 2025 | $51.69M | +806.4% | -13.6% |
| Diluted EPS | October 31, 2025 | $0.59 | +883.3% | -13.2% |
| Total Assets | October 31, 2025 | $3.40B | -2.6% | -0.5% |
| Cash and Equivalents | October 31, 2025 | $309.26M | -4.0% | +1.6% |
| Long-Term Debt | October 31, 2025 | $982.11M | -9.2% | -2.5% |
| Stockholders Equity | October 31, 2025 | $2.13B | +0.4% | -0.6% |
| R&D Expense | October 31, 2025 | $65.92M | +9.5% | +1.7% |
| Operating Income | October 31, 2025 | $78.69M | +301.0% | -12.2% |
| Gross Profit | October 31, 2025 | $228.06M | +15.8% | -1.9% |
| Shares Outstanding | October 31, 2025 | 85.61M | -1.4% | -0.9% |
- HEALTHEQUITY, INC. reported Total Revenue of $1.31 billion for fiscal year 2026.
- HEALTHEQUITY, INC. showed an increase of +9.5% in Total Revenue compared to the prior fiscal year.
- HEALTHEQUITY, INC. reported Revenue (ASC 606) of $1.31 billion for fiscal year 2026.
- HEALTHEQUITY, INC. showed an increase of +9.5% in Revenue (ASC 606) compared to the prior fiscal year.
- HEALTHEQUITY, INC. reported Net Income of $215.20 million for fiscal year 2026.
- HEALTHEQUITY, INC. showed an increase of +122.5% in Net Income compared to the prior fiscal year.
- HEALTHEQUITY, INC. reported Diluted EPS of $2.46 per share for fiscal year 2026.
- HEALTHEQUITY, INC. showed an increase of +125.7% in Diluted EPS compared to the prior fiscal year.
- HEALTHEQUITY, INC. reported Total Assets of $3.38 billion for fiscal year 2026.
- HEALTHEQUITY, INC. showed a decrease of -2.0% in Total Assets compared to the prior fiscal year.
- HEALTHEQUITY, INC. reported Cash and Equivalents of $318.93 million for fiscal year 2026.
- HEALTHEQUITY, INC. showed an increase of +7.8% in Cash and Equivalents compared to the prior fiscal year.
- HEALTHEQUITY, INC. reported Long-Term Debt of $957.38 million for fiscal year 2026.
- HEALTHEQUITY, INC. showed a decrease of -9.4% in Long-Term Debt compared to the prior fiscal year.
- HEALTHEQUITY, INC. reported Stockholders Equity of $2.11 billion for fiscal year 2026.
- HEALTHEQUITY, INC. showed a decrease of -0.4% in Stockholders Equity compared to the prior fiscal year.
- HEALTHEQUITY, INC. reported R&D Expense of $262.51 million for fiscal year 2026.
- HEALTHEQUITY, INC. showed an increase of +9.6% in R&D Expense compared to the prior fiscal year.
- HEALTHEQUITY, INC. reported Operating Income of $322.46 million for fiscal year 2026.
- HEALTHEQUITY, INC. showed an increase of +98.6% in Operating Income compared to the prior fiscal year.
- HEALTHEQUITY, INC. reported Gross Profit of $913.12 million for fiscal year 2026.
- HEALTHEQUITY, INC. showed an increase of +17.5% in Gross Profit compared to the prior fiscal year.
- HEALTHEQUITY, INC. reported Shares Outstanding of 85.01 million shares for fiscal year 2026.
- HEALTHEQUITY, INC. showed a decrease of -1.8% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: